Nakamura et al. reported downregulation of SEGN in SCLC, while Nomura et al. reported upregulation, even though both studies used FFPE tumor samples and the LC-MS/MS proteomic technique. The gene discussed is SCGN; the disease is small cell lung carcinoma.